Effect of lovastatin and bezafibrate on cyclosporine-induced hyperlipidemia in rabbits.
Hidalgo
L
L
Unidad de Lipidos y Arteriosclerosis, Hospital Universitario Reina Sofía, Córdoba, Spain.
López-Miranda
J
J
Espino
A
A
Alcala
J
J
Blanco
J
J
Prada
J L
JL
Rodríguez
M
M
Jiménez-Perepérez
J A
JA
Jansen
S
S
Pérez-Jiménez
F
F
D000818:Animals; D001629:Bezafibrate / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D016572:Cyclosporine / Q000633:toxicity*; D006949:Hyperlipidemias / Q000139:chemically induced / Q000188:drug therapy*; D007700:Kinetics; D008074:Lipoproteins / Q000097:blood*; D008148:Lovastatin / Q000627:therapeutic use*; D011817:Rabbits; D014280:Triglycerides / Q000097:blood*
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D008074:Lipoproteins; D014280:Triglycerides; C030104:lipoprotein cholesterol; D016572:Cyclosporine; D002784:Cholesterol; D008148:Lovastatin; D001629:Bezafibrate